FDA Inspection
Strides Pharma Inc.Strides Pharma Inc. – FDA Inspection, Apr 18, 2018
Record Details
This FDA Inspection record concerns Strides Pharma Inc., with an inspection on April 18, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · df800a9c-7a50-4b81-9326-f3634cb12ee5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049638
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Strides Pharma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2024 | NAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Strides Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.